Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2023 / Jun / Laser Focus on Glaucoma Treatment
Business and Entrepreneurship Practice Management Glaucoma Sponsored

Laser Focus on Glaucoma Treatment

Karsten Klabe discusses the ELIOS procedure – and describes the long-lasting benefits for his glaucoma patients

Sponsored By Elios Vision 6/2/2023 2 min read

Share

Figure 1. Microchannel patency at 31 months (1).

Please tell us about your recent adoption of ELIOS...
 

One of the recurring motifs in our office is our love of lasers. We’ve used lasers for decades, which made the adoption of ELIOS natural. In my opinion, ELIOS is the most adoptable trabecular bypass procedure, so it’s not only for glaucoma specialists but also anterior segment surgeons who are experienced with gonioscope guided angle surgery and trabecular meshwork anatomy. There are important differences between the excimer lasers used in refractive surgery, which use much shorter wavelengths of light, and ELIOS, which uses an excimer laser with a wavelength of 308 nm. Specifically, the ELIOS excimer laser gives us the ability to transport laser energy to the trabecular meshwork through an optical fiber in a specially designed probe, which results in an excellent safety profile. Why? Because such precise excimer ablation of trabecular meshwork tissues causes no collateral damage to the cornea or the iris.

Meet Karsten Klabe
 

My name is Dr Karsten Klabe and I’ve been working in a private practice for seven years. I was formerly the head of the eye department for ten years at the Marien Hospital in Düsseldorf, Germany. I’ve been working as a glaucoma specialist for around 20 years – and, as far as I know, I ́m one of the earliest adopters of MIGS in the area of North Rhine-Westphalia. After all this time, I’m still interested in introducing new surgical approaches in the field of glaucoma

For which patients is ELIOS suitable?
 

All that’s required for ELIOS is an open angle. The procedure is independent of pigment in the trabecular meshwork compared with ALT/SLT. Additionally, it’s not only suited to combined cases, and can be performed standalone. I use it on any patient where the target pressure is no lower than 14 mmHg. We know that the percentage of IOP lowering is between 20–40 percent – suitable for around half of my patients. My preference for ELIOS is patients with one or two medications pre-op, and pressure no higher than 30 mmHg; these patients have a very good chance of being medication free post-surgery. Previous SLT is not a contraindication, as the mechanism of action is completely different, meaning the microchannels can still be created using the ELIOS excimer laser.

What should a referring doctor know about ELIOS?
 

It’s a safe and effective procedure and in general, the post-op of ELIOS is comparable to cataract surgery – you see an immediate effect following surgery.

References

  1. Berlin MS, Shakibkhou J, Tilakaratna N, Giers U, Groth SL. J Cataract Refract Surg. 2022 Jul.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: